Bicarbonate therapy for unstable propafenone-induced wide complex tachycardia

Canadian Journal of Emergency Medicine

Volumn 6, Issue 5, 2004, Pages 349-356

  Brubacher, Jeff ^a,b,c  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c British Columbia Drug and Poison Information Centre   (Canada)

Author keywords

Adverse effects; Anti arrhythmia agents; Atrial fibrillation; Propafenone; Sodium channel blockers

Indexed keywords

ADRENALIN; BICARBONATE; DILTIAZEM; DOPAMINE; HYPERTONIC SOLUTION; LIDOCAINE; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL;

AGED; ARTICLE; BLOOD PRESSURE; CARDIOTOXICITY; CASE REPORT; DEFIBRILLATION; DYSPNEA; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; LABORATORY TEST; PHYSICAL EXAMINATION; QRS COMPLEX; SINUS RHYTHM;

EID: 18244395044     PISSN: 14818035     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1481803500009635     Document Type: Article

References (61)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of a trial fibrillation on the risk of death: the framingham heart study. Circulation 1998;98(10):946-52.
2. Falk R H. Atrial fibrillation. N Engl J Med 2001;344(14):1067-78.
3. Schreck DM, Rivera AR, Tricarico VJ. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin. Ann Emerg Med 1997;29(1):135-40.
4. Segal JB, McNamara RL, Miller MR, Kim N, Goodman SN, Powe NR, et al. The evidence regarding the drugs used for ventricular rate control. J Fam Pract 2000;49(1):47-59.
5. Crozier I, Melton I, Pearson S. Management of atrial fibrillation in the emergency department. Intern Med J 2003;33(4):182-5.
6. Stoddard MF. Risk of thromboembolism in new onset or transient atrial fibrillation. Progr Cardiovasc Dis 1996;39(1):69-80.
7. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995;25(2):452-9.
8. Stoddard MF, Singh P, Dawn B, Longaker RA. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 2003;145(4):676-82.
9. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347(23):1834-40.
10. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347(23):1825-33.
11. Falk RH. Managment of atrial fibrillation - radical reform or modest modification? N Engl J Med 2002;347(23):1883-4.
12. Hughes C, Sunderji R, Gin K. Oral propafenone for rapid conversion of recent onset atrial fibrillation - A review. Can J Cardiol 1997;13(9):839-42.
13. Khan IA. Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset a trial fibrillation. J Am Coll Cardiol 2001;37(2):542-7.
14. Kowey PR, Marinchak RA, Rials SJ, Bharucha DB. Classification and pharmacology of antiarrhythmic drugs. Am Heart J 2000;140(1):12-20.
15. Kolecki PF, Curry SC. Poisoning by sodium channel blocking agents. Crit Care Clin 1997;13(4):829-48.
16. Koppel C, Oberdisse U, Heinemeyer G. Clinical course and outcome in class IC antiarrhythmic overdose. J Toxicol Clin Toxicol 1990;28(4):433-44.
17. Henry JA, Cassidy SL. Membrane stabilising activity: a major cause of fatal poisoning. Lancet 1986;1:1414-7.
18. McHugh TP, Perina DG. Propafenone ingestion. Ann Emerg Med 1987;16(4):437-40.
19. Molia AC, Tholon JP, Lamiable DL, Trenque TC. Unintentional pediatric overdose of propafenone. Ann Pharmacotherapy 2003;37(7-8):1147-8.
20. Sadeg N, Richecoeur J, Dumontet M. [Propafenone poisoning]. Therapie 2003;58(4):381-3; discussion 387.
21. Maxeiner H, Klug E. Lethal suicidal intoxication with propafenone, after a history of self-inflicted injuries. Forensic Sci Int 1997;89(1-2):27-32.
22. Fray O, Fowler J. Severe propafenone poisoning responded to temporary internal pacemaker. Vet Hum Toxicol 2000;42(5):289.
23. Fonck K, Haenebalcke C, Hemeryck A, Belpaire F, Jordaens L, Calle P, et al. ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning. J Toxicol Clin Toxicol 1998;36(3):247-51.
24. Kerns W 2nd, English B, Ford M. Propafenone overdose. Ann Emerg Med 1994;24(1):98-103.
25. Rambourg-Schepens MO, Grossenbacher F, Buffet M, Lamiable D. Recurrent convulsions and cardiac conduction disturbances after propafenone overdose. Vet Hum Toxicol 1999;41(3):153-4.
26. Friocourt P, Martin C, Lozac'h L. [Self-poisoning with propafenone. Apropos of a case]. [French]. Annales de Cardiologie et d Angeiologie 1988;37:(3)133-6.
27. Olm M, Jimenez MJ, Munne P. [Efficacy of intravenous methoxamine in propafenone poisoning]. Presse Med 1989;18(22):1124.
28. Palette C, Maroun N, Gaulier JM, Priolet B, Lachatre G, Bedos JP, et al. [Fatal poisoning with propafenone: a case report documented with blood concentration levels]. Therapie 2003;58(4):384-6; discussion 387.
29. Cocozzella D, Curciarello J, Corallini O, Olivera A, Alburquerque MM, Fraquelli E, et al. Propafenone hepatotoxicity: report of two new cases. Dig Dis Sci 2003;48(2):354-7.
30. Gandolfi A, Rota E, Zanghieri G, Tolomelli S, Bagnulo A, Mengoli M. [Acute cholestatic hepatitis caused by propafenone. Report of a case and review of the literature]. Recenti Prog Med 2001;92(3):197-9.
31. Grieco A, Forgione A, Giorgi A, Miele L, Gasbarrini G. Propafenone-related cholestatic hepatitis in an elderly patient. Ital Heart J 2002;3(7):431-4.
32. Mondardini A, Pasquino P, Bernardi P, Aluffi E, Tartaglino B, Mazzucco G, et al. Propafenone-induced liver injury: report of a case and review of the literature. Gastroenterology 1993;104(5):1524-6.
33. Schuppel R, Probst M. Acute cholestatic hepatitis and the sudden rise of the pacing threshold 5 weeks after vvi-pacemaker implantation. J Intern Med 1994;236(3):353-6.
34. Spinler SA, Elder CA, Kindwall KE. Propafenone-induced liver injury. Ann Pharmacotherapy 1992;26(7-8):926-8.
35. Hill MR, Gotz VP, Harman E, McLeod I, Hendeles L. Evaluation of the asthmogenicity of propafenone, a new antiarrhythmic drug. Comparison of spirometry with methacholine challenge. Chest 1986;90(5):698-702.
36. Olm M, Munne P, Jimenez MJ. Severe reactive airways disease induced by propafenone. Chest 1989;95(6):1366-7.
37. Miwa LJ, Jolson HM. Propafenone associated agranulocytosis. Pacing Clin Electrophysiol 1992;15(4 Pt 1):387-90.
38. Zeng ZQ, Zhu L. [Hemolytic reaction resulting from propafenone administration.] Zhonghua Nei Ke Za Zhi 1991;30(4):217-8.
39. O'Rourke DJ, Palac RT, Holzberger PT, Gerling BR, Greenberg ML. Propafenone-induced drug fever in the absence of agranulocytosis. Clin Cardiol 1997;20(7):662-4.
40. Odeh M, Seligmann H, Oliven A. Propafenone-induced ataxia: report of three cases. Am J Med Sci 2000;320(2):151-3.
41. Nathan AW, Bexton RS, Hellestrand KJ, Camm AJ. Fatal ventricular tachycardia in association with propafenone, a new class IC antiarrhythmic agent. Postgrad Med J 1984;60:155-6.
42. Buss J, Neuss H, Bilgin Y, Schlepper M. Malignant ventricular tachyarrhythmias in association with propafenone treatment. Eur Heart J 1985;6:424-8.
43. Camous JP, Ichai C, Meyer P, Gibelin P, Baudouy M, Varenne A, et al. [Treatment of poisoning caused by new anti-arrhythmia agents (cibenzoline, flecainide and propafenone)]. Presse Med 1987;16(41):2076.
44. De Jaegere P, Huyghens L, Dewilde P. Sustained ventricular tachycardia occurring during propafenone therapy. Acta Cardiol 1987;42(3):207-12.
45. Millar RN, Lawrenson JB, Milne DA. Normal left ventricular function does not protect against propafenone-induced incessant ventricular tachycardia. S Afr Med J 1993;83(4):256-9.
46. Moroe K, Annoura M, Matsuo K, Yamanouchi Y, Kumagai K, Arakawa K. Proarrhythmic effects of classic drugs. Clin Ther 1993;15(3):559-66.
47. Rosengarten M, Brooks R. Torsade de pointes ventricular tachycardia in a hypothyroid patient treated with propafenone. Ca J Cardiol 1987;3(5):234-9.
48. Scanu P, Grollier G, Guilleman D, Iselin M, Bustany P, Hurpe JM, et al. Malignant ventricular tachycardia during propafenone treatment in a child with junctional automatic tachycardia: effectiveness of intravenous molar sodium lactate. Pacing Clin Electrophysiol 1991;14(5 Pt 1):783-6.
49. Bauman JL, Gallastegui J, Tanenbaum SR, Hariman RJ. Flecainide-induced sustained ventricular tachycardia successfully treated with lidocaine. Chest 1987;92(3):573-5.
50. Lau W, Newman D, Dorian P. Can antiarrhythmic agents be selected based on mechanism of action? Drugs 2000;60(6):1315-28.
51. Siegers A, Board PN. Amiodarone used in successful resuscitation after near-fatal flecainide overdose. Resuscitation 2002;53(1):105-8.
52. Winecoff AP, Hariman RJ, Grawe JJ, Wang Y, Bauman JL. Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 1. Comparison with sodium bicarbonate and quinidine. Pharmacotherapy 1994;14(6):698-703.
53. Bou-Abboud E, Nattel S. Relative role of alkalosis and sodium ions in reversal of class I antiarrhythmic drug-induced sodium channel blockade by sodium bicarbonate. Circulation 1996;94(8):1954-61.
54. Goldman MJ, Mowry JB, Kirk MA. Sodium bicarbonate to correct widened QRS in a case of flecainide overdose. J Emerg Med 1997;15(2):183-6.
55. Kerns W 2nd, Garvey L, Owens J. Cocaine-induced wide complex dysrhythmia. J Emerg Med 1997;15(3):321-9.
56. Keyler DE, Pentel PR. Hypertonic sodium bicarbonate partially reverses QRS prolongation due to flecainide in rats. Life Sci 1989;45(17):1575-80.
57. Parker RB, Perry GY, Horan LG, Flowers NC. Comparative effects of sodium bicarbonate and sodium chloride on reversing cocaine-induced changes in the electrocardiogram. J Cardiovasc Pharmacol 1999;34(6):864-9.
58. Salerno DM, Murakami MM, Johnston RB, Keyler DE, Pentel PR. Reversal of flecainide-induced ventricular arrhythmia by hypertonic sodium bicarbonate in dogs. Am J Emerg Med 1995;13(3):285-93.
59. Lovecchio F, Berlin R, Brubacher JR, Sholar JB. Hypertonic sodium bicarbonate in an acute flecainide overdose. Am J Emerg Med 1998;16(5):534-7.
60. Lanquetot H, Furet Y, Kerouredan V, Poitrineau O, Hubiche M, Autret E. [Fatal poisoning caused by the combination propafenone-amitriptyline; a propos of a case.] Agressologie 1988;29(1):39-42.
61. Roden DM. Antiarhythmic drugs. In: Goodman and Gilman's The pharmacologic basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996. 839-74.